Neutrogena-owner Kenvue Inc. announced on Monday the appointment of Kirk Perry as interim chief executive officer, effective immediately.

Perry, a current Kenvue board member, succeeds Thibaut Mongon, who has stepped down from the CEO role and the board. The company has engaged executive search firm Heidrick & Struggles to identify a permanent CEO.

The leadership changes come as Kenvue’s board continues a comprehensive review process to optimize the company’s brand portfolio and operational structure. The previously established Strategic Review Committee is evaluating a broad range of options to enhance execution, simplify the organization, and better position Kenvue for profitable growth.

“Kenvue has world-class brands in attractive categories and a strong global platform. The actions announced today are to ensure we have the right talent, brand portfolio and operational foundation to fully capitalize on those strengths, accelerate profitable growth and best position the company for future success,” said Larry Merlo, Kenvue’s chair of the board. 

“The board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to simplify the Company’s portfolio and how it operates. At the same time, with the CEO transition and recent appointment of a new CFO, we are aligning leadership expertise to drive the company forward.”

Perry brings more than three decades of experience across consumer-packaged goods and digital transformation. He most recently served as president and CEO of Circana, following its rebrand and merger of IRI and The NPD Group. His previous roles include senior leadership positions at Google and Procter & Gamble.

“I have seen firsthand Kenvue’s many strengths and share the Board’s confidence in the Company’s growth and value creation opportunities,” said Perry. 

“As interim CEO, I am excited to leverage my decades of experience leading businesses across the consumer and technology industries and work with the Board and leadership team to put the business on the strongest footing to deliver on Kenvue’s full potential and realize our goal of top-tier financial performance.”

Coinciding with the appointment, Kenvue released select preliminary financial results for the second quarter. The company reported a net sales decline of 4%, with organic sales down 4.2%. Diluted earnings per share are expected to range between $0.21 and $0.22, with adjusted EPS between $0.28 and $0.29. 

Full second-quarter results and a revised 2025 outlook will be shared on August 7.